ENTITY
MicroPort CardioFlow

MicroPort CardioFlow (2160 HK)

63
Analysis
Health Care • China
MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.
more
bullish•Kuaishou Technology
•17 Jan 2021 00:31

ECM Weekly (17 January 2021) - RLX Tech, Kuaishou, PTT Retail, MicroPort CardioFlow, New Horizon

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•13 Jan 2021 13:49

MicroPort Cardioflow (å¾®åˆ›åæƒé€š) Pre-IPO: Strong Sales Ramp-Up Despite Being Late in Market

The company's first-generation TAVR, VitaFlow, has decent clinical data in terms of efficacy and safety. It was launched two years behind VenusA...

Logo
628 Views
Share
bullish•Yidu Tech
•10 Jan 2021 13:45

ECM Weekly (10 January 2021) - RLX Technology, Roiserv, Yidu Tech, and Placements

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•10 Jan 2021 01:26

Microport Cardioflow: Winning in TAVR

We provide our initial thoughts on the proposed listing of medical device (TAVR) company MicroPort Cardioflow on the HKEX.

Share
•16 Dec 2020 09:23

Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?

This article analyzed the market potential of TAVR in China, competition pattern of key players, financial position of MicroPort CardioFlow and...

Logo
662 Views
Share
x